Кетогенная Терапия как метод лечения переедания и зависимости от сверхпереработанной пищи

22 января 2024

! American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.

Baenas, I., Miranda-Olivos, R., Solé-Morata, N., Jiménez-Murcia, S., & Fernández-Aranda, F. (2023). Neuroendocrinological factors in binge eating disorder: A narrative review. Psychoneuroendocrinology, 150, 106030. https://doi.org/10.1016/j.psyneuen.2023.106030

Balodis, I. M., Kober, H., Worhunsky, P. D., White, M. A., Stevens, M. C., Pearlson, G. D., Sinha, R., Grilo, C. M., & Potenza, M. N. (2013). Monetary Reward Processing in Obese Individuals With and Without Binge Eating Disorder. Biological Psychiatry, 73(9), 877–886. https://doi.org/10.1016/j.biopsych.2013.01.014

Blanco-Gandia, M. C., Montagud-Romero, S., & Rodríguez-Arias, M. (2021). Binge eating and psychostimulant addiction. World Journal of Psychiatry, 11(9), 517–529. https://doi.org/10.5498/wjp.v11.i9.517

Breton, E., Fotso Soh, J., & Booij, L. (2022). Immunoinflammatory processes: Overlapping mechanisms between obesity and eating disorders? Neuroscience & Biobehavioral Reviews, 138, 104688. https://doi.org/10.1016/j.neubiorev.2022.104688

Butler, M. J., Perrini, A. A., & Eckel, L. A. (2021). The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders. Nutrients, 13(2), Article 2. https://doi.org/10.3390/nu13020500

Chung, J. Y., Kim, O. Y., & Song, J. (2022). Role of ketone bodies in diabetes-induced dementia: Sirtuins, insulin resistance, synaptic plasticity, mitochondrial dysfunction, and neurotransmitter. Nutrition Reviews, 80(4), 774–785. https://doi.org/10.1093/nutrit/nuab118

Dahlin, M., Månsson, J.-E., & Åmark, P. (2012). CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy. Epilepsy Research, 99(1), 132–138. https://doi.org/10.1016/j.eplepsyres.2011.11.003

Donnelly, B., Touyz, S., Hay, P., Burton, A., Russell, J., & Caterson, I. (2018). Neuroimaging in bulimia nervosa and binge eating disorder: A systematic review. Journal of Eating Disorders, 6(1), 3. https://doi.org/10.1186/s40337-018-0187-1

Feng, B., Harms, J., Chen, E., Gao, P., Xu, P., & He, Y. (2023). Current Discoveries and Future Implications of Eating Disorders. International Journal of Environmental Research and Public Health, 20(14), Article 14. https://doi.org/10.3390/ijerph20146325

Gano, L. B., Patel, M., & Rho, J. M. (2014). Ketogenic diets, mitochondria, and neurological diseases. Journal of Lipid Research, 55(11), 2211–2228. https://doi.org/10.1194/jlr.R048975

Guardia, D., Rolland, B., Karila, L., & Cottencin, O. (2011). GABAergic and Glutamatergic Modulation in Binge Eating: Therapeutic Approach. Current Pharmaceutical Design, 17(14), 1396–1409. https://doi.org/10.2174/138161211796150828

Hilbert, A., Petroff, D., Herpertz, S., Pietrowsky, R., Tuschen-Caffier, B., Vocks, S., & Schmidt, R. (2020). Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder. International Journal of Eating Disorders, 53(9), 1353–1376. https://doi.org/10.1002/eat.23297

Jiang, Z., Yin, X., Wang, M., Chen, T., Wang, Y., Gao, Z., & Wang, Z. (2022). Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases. Aging and Disease, 13(4), 1146-1165. https://doi.org/10.14336/AD.2021.1217

Kessler, R. M., Hutson, P. H., Herman, B. K., & Potenza, M. N. (2016). The neurobiological basis of binge-eating disorder. Neuroscience & Biobehavioral Reviews, 63, 223–238. https://doi.org/10.1016/j.neubiorev.2016.01.013

Knowles, S., Budney, S., Deodhar, M., Matthews, S. A., Simeone, K. A., & Simeone, T. A. (2018). Ketogenic diet regulates the antioxidant catalase via the transcription factor PPARγ2. Epilepsy Research, 147, 71–74. https://doi.org/10.1016/j.eplepsyres.2018.09.009

Levitan, M. N., Papelbaum, M., Carta, M. G., Appolinario, J. C., & Nardi, A. E. (2021). Binge Eating Disorder: A 5-Year Retrospective Study on Experimental Drugs. Journal of Experimental Pharmacology, 13, 33–47. https://doi.org/10.2147/JEP.S255376

Mele, G., Alfano, V., Cotugno, A., & Longarzo, M. (2020). A broad-spectrum review on multimodal neuroimaging in bulimia nervosa and binge eating disorder. Appetite, 151, 104712. https://doi.org/10.1016/j.appet.2020.104712

Meng, Y., & Kautz, A. (2022). An evidence review of the association of immune and inflammatory markers with obesity-related eating behaviors. Frontiers in Immunology, 13. https://www.frontiersin.org/articles/10.3389/fimmu.2022.902114

Milder, J., & Patel, M. (2012). Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Research, 100(3), 295–303. https://doi.org/10.1016/j.eplepsyres.2011.09.021

Morris, A. a. M. (2005). Cerebral ketone body metabolism. Journal of Inherited Metabolic Disease, 28(2), 109–121. https://doi.org/10.1007/s10545-005-5518-0

Murray, S. L., & Holton, K. F. (2021). Post-traumatic stress disorder may set the neurobiological stage for eating disorders: A focus on glutamatergic dysfunction. Appetite, 167, 105599. https://doi.org/10.1016/j.appet.2021.105599

Norwitz, N. G., Dalai, S. S., & Palmer, C. M. (2020). Ketogenic diet as a metabolic treatment for mental illness. Current Opinion in Endocrinology, Diabetes and Obesity, 27(5), 269–274. https://doi.org/10.1097/MED.0000000000000564

Oliveira, T. P. D., Gonçalves, B. D. C., Oliveira, B. S., de Oliveira, A. C. P., Reis, H. J., Ferreira, C. N., Aguiar, D. C., de Miranda, A. S., Ribeiro, F. M., Vieira, E. M. L., Palotás, A., & Vieira, L. B. (2021). Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior. Frontiers in Neuroscience, 15. https://www.frontiersin.org/articles/10.3389/fnins.2021.631311

Pietrzak, D., Kasperek, K., Rękawek, P., & Piątkowska-Chmiel, I. (2022). The Therapeutic Role of Ketogenic Diet in Neurological Disorders. Nutrients, 14(9), Article 9. https://doi.org/10.3390/nu14091952

Polito, R., La Torre, M. E., Moscatelli, F., Cibelli, G., Valenzano, A., Panaro, M. A., Monda, M., Messina, A., Monda, V., Pisanelli, D., Sessa, F., Messina, G., & Porro, C. (2023). The Ketogenic Diet and Neuroinflammation: The Action of Beta-Hydroxybutyrate in a Microglial Cell Line. International Journal of Molecular Sciences, 24(4), Article 4. https://doi.org/10.3390/ijms24043102

Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology—David J Heal, Sharon L Smith, 2022. (n.d.). Retrieved January 17, 2024, from https://journals.sagepub.com/doi/full/10.1177/02698811211032475

Pruccoli, J., Parmeggiani, A., Cordelli, D. M., & Lanari, M. (2021). The Role of the Noradrenergic System in Eating Disorders: A Systematic Review. International Journal of Molecular Sciences, 22(20), Article 20. https://doi.org/10.3390/ijms222011086

Ratković, D., Knežević, V., Dickov, A., Fedrigolli, E., & Čomić, M. (2023). Comparison of binge-eating disorder and food addiction. Journal of International Medical Research, 51(4), 03000605231171016. https://doi.org/10.1177/03000605231171016

Rostanzo, E., Marchetti, M., Casini, I., & Aloisi, A. M. (2021). Very-Low-Calorie Ketogenic Diet: A Potential Treatment for Binge Eating and Food Addiction Symptoms in Women. A Pilot Study. International Journal of Environmental Research and Public Health, 18(23), Article 23. https://doi.org/10.3390/ijerph182312802

Ruiz-Guerrero, F., Gomez del Barrio, A., de la Torre-Luque, A., Ayad-Ahmed, W., Beato-Fernandez, L., Polo Montes, F., Leon Velasco, M., MacDowell, K. S., Leza, J. C., Carrasco, J. L., & Díaz-Marsá, M. (2023). Oxidative stress and inflammatory pathways in female eating disorders and borderline personality disorders with emotional dysregulation as linking factors with impulsivity and trauma. Psychoneuroendocrinology, 158, 106383. https://doi.org/10.1016/j.psyneuen.2023.106383

Schreiber, L. R. N., Odlaug, B. L., & Grant, J. E. (2013). The overlap between binge eating disorder and substance use disorders: Diagnosis and neurobiology. Journal of Behavioral Addictions, 2(4), 191–198. https://doi.org/10.1556/JBA.2.2013.015

Simeone, T. A., Matthews, S. A., Samson, K. K., & Simeone, K. A. (2017). Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy. Experimental Neurology, 287, 54–64. https://doi.org/10.1016/j.expneurol.2016.08.006

Sokoloff, L. (1973). Metabolism of Ketone Bodies by the Brain. Annual Review of Medicine, 24(1), 271–280. https://doi.org/10.1146/annurev.me.24.020173.001415

Tao, Y., Leng, S. X., & Zhang, H. (2022). Ketogenic Diet: An Effective Treatment Approach for Neurodegenerative Diseases. Current Neuropharmacology, 20(12), 2303–2319. https://doi.org/10.2174/1570159X20666220830102628

Yang, B. (2021). When to Stop Eating: An Auxiliary Brake on Food Consumption from the Nucleus Accumbens. Journal of Neuroscience, 41(9), 1847–1849. https://doi.org/10.1523/JNEUROSCI.1666-20.2020

Yohn, S. E., Galbraith, J., Calipari, E. S., & Conn, P. J. (2019). Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway. ACS Chemical Neuroscience, 10(5), 2125–2143. https://doi.org/10.1021/acschemneuro.8b00601

Yu, Y., Fernandez, I. D., Meng, Y., Zhao, W., & Groth, S. W. (2021). Gut hormones, adipokines, and pro- and anti-inflammatory cytokines/markers in loss of control eating: A scoping review. Appetite, 166, 105442. https://doi.org/10.1016/j.appet.2021.105442

Yu, Y., Miller, R., & Groth, S. W. (2022). A literature review of dopamine in binge eating. Journal of Eating Disorders, 10(1), 11. https://doi.org/10.1186/s40337-022-00531-y